| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/02/1998 | CA2213257A1 Oligopeptide derivatives |
| 04/01/1998 | EP0832846A2 Complexes of polymer and hydrogen peroxide |
| 04/01/1998 | EP0832645A1 Cosmetic composition comprising a particular copolymer and use of said copolymer in cosmetics |
| 04/01/1998 | EP0832446A1 Therapeutic microdevices and methods of making and using same |
| 04/01/1998 | EP0832272A1 Cationic lipid:dna complexes for gene targeting |
| 04/01/1998 | EP0832270A1 Cationic lipid:dna complexes for gene targeting |
| 04/01/1998 | EP0832269A1 Nucleic acid transporters for delivery of nucleic acids into a cell |
| 04/01/1998 | EP0832220A1 Ob protein compositions and method |
| 04/01/1998 | EP0832151A2 Responsive polymer networks and methods of their use |
| 04/01/1998 | EP0832111A1 Modified avidin and streptavidin and methods of use thereof |
| 04/01/1998 | EP0831932A1 Novel targeted compositions for diagnostic and therapeutic use |
| 04/01/1998 | EP0831927A1 Stabilized compositions of fluorinated amphiphiles as contrast agents for ultrasound |
| 04/01/1998 | EP0831923A1 Separation of active complexes |
| 04/01/1998 | EP0831922A2 Improved pharmaceutical compositions for gene therapy |
| 04/01/1998 | EP0831918A2 Drug mitochondrial targeting agents |
| 04/01/1998 | EP0831917A2 Immunotoxins specific for cd80 and cd86 expressing cells |
| 04/01/1998 | EP0831916A1 Treatment of cholera |
| 04/01/1998 | EP0831915A1 Treatment of cholera |
| 04/01/1998 | EP0831914A1 Treatment of traveller's diarrhea |
| 04/01/1998 | EP0831913A1 Treatment of traveller's diarrhea |
| 04/01/1998 | EP0831912A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 04/01/1998 | EP0831905A1 Methods of treating colon cancer utilizing tumor-specific antibodies |
| 04/01/1998 | EP0831894A1 Immunogenic and immunostimulatory oligosaccharide compositions and methods of making and using them |
| 04/01/1998 | EP0831886A1 Thrombopoietin compositions |
| 04/01/1998 | EP0831884A1 Methods and compositions for healing and repair of connective tissue attachment |
| 04/01/1998 | EP0831870A1 Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| 04/01/1998 | EP0831867A1 Collagen-based delivery matrix |
| 04/01/1998 | EP0831858A1 Intrauterine chemical necrosing method and composition |
| 04/01/1998 | EP0831857A2 Phosphate-binding polymers for oral administration |
| 04/01/1998 | EP0831856A2 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 04/01/1998 | EP0831850A1 Use of locally applied dna fragments |
| 04/01/1998 | EP0831827A1 Novel formulations for transdermal delivery of pergolide |
| 04/01/1998 | EP0831826A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 04/01/1998 | EP0831825A1 Pharmaceutical formulations of highly lipophilic camptothecin derivatives |
| 04/01/1998 | EP0831820A1 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
| 04/01/1998 | EP0831817A1 Antigen-processing cell-targeted conjugates |
| 04/01/1998 | EP0831808A1 Osteogenetic promoting pharmaceutical composition |
| 04/01/1998 | EP0831803A1 Sorbic-acid-containing hydrogels |
| 04/01/1998 | EP0831796A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors |
| 04/01/1998 | EP0831793A1 Protein particles for therapeutic and diagnostic use |
| 04/01/1998 | EP0831792A2 Apparatus and method for delivering a biologically active compound into a biological environment |
| 04/01/1998 | EP0831791A1 Delivery of drugs to the lower gi tract |
| 04/01/1998 | EP0831789A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
| 04/01/1998 | EP0831787A2 Composition for sustained release of human growth hormone |
| 04/01/1998 | EP0831786A2 Device for releasing aggregation-stabilized, biologically active agent |
| 04/01/1998 | EP0831776A2 Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir |
| 04/01/1998 | EP0831773A1 Peptide/protein suspended formulations |
| 04/01/1998 | EP0831768A1 Topical vehicles containing solubilized and stabilized azelaic acid |
| 04/01/1998 | EP0831767A1 Alpha hydroxyacid esters for skin aging |
| 04/01/1998 | EP0831727A1 Fat substitutes containing water soluble beta-caroten |
| 04/01/1998 | EP0831703A1 Method of solubilizing and encapsulating itraconazole |
| 04/01/1998 | EP0800364A4 Transdermal administration of apomorphine |
| 04/01/1998 | EP0799047A4 Viscous liquid conditioning topical germicides |
| 04/01/1998 | EP0788348A4 Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 04/01/1998 | EP0746292A4 Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters |
| 04/01/1998 | EP0716599B1 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-$g(b)-ESTRADIOL AND PROCESS FOR ITS PRODUCTION |
| 04/01/1998 | EP0695161B1 Cosmetic and medicinal topical preparations |
| 04/01/1998 | CN1177927A Extracts of shark cartilage, process of production and uses thereof |
| 04/01/1998 | CN1177922A Oil in water emulsions containing 2, 6 -diisopropyl phenic and ehtylenedinamine-tetra acetic salt |
| 04/01/1998 | CN1177637A Preparation of living bacillus subtilis and preparation method thereof |
| 04/01/1998 | CN1177636A Bacterial stain of bacillus subtilis and application thereof |
| 04/01/1998 | CN1177480A Preparation absorbed through skin, containing woluoke kinds of medicine |
| 03/31/1998 | US5733950 Dissolving water insoluble biodegradable thermoplastic polymer in biocompatible water soluble solvent, placing in body, allowing solvent to dissipate or diffuse into body fluid and polymer to coagulate or solidify to form implant |
| 03/31/1998 | US5733930 Topical gel; anaesthesia |
| 03/31/1998 | US5733925 Administering taxol treating cardiovascular disorder |
| 03/31/1998 | US5733919 Compositions for inhibiting platelet aggregation |
| 03/31/1998 | US5733900 Percutaneous administration base composition and percutaneous administration medicinal composition comprising said base composition and medicine |
| 03/31/1998 | US5733891 Compound for medicinal ingredient and hyaluronic acid and process for producing the same |
| 03/31/1998 | US5733888 Injectable composition |
| 03/31/1998 | US5733885 Heat treatment of blood for safety |
| 03/31/1998 | US5733877 Pharmaceutical composition containing biologically active peptide or protein |
| 03/31/1998 | US5733874 Stable dry powders |
| 03/31/1998 | US5733873 Polyoxamers or polyoxyethylene sorbitan fatty acid esters with sodium chloride, calcium chloride, histidine or sugars |
| 03/31/1998 | US5733870 Ointment for treatment of epithelial lesions |
| 03/31/1998 | US5733762 Conjugated glycoproteins for drug delivery |
| 03/31/1998 | US5733578 Directly compressible high load acetaminophen formulations |
| 03/31/1998 | US5733575 Dry powder mixture of polymer, detackifier, viscosity modifier, alkalizing agent, solid and liquid plasticizers, lubricant, anticaking agent and pigment, for coating drug tablets |
| 03/31/1998 | US5733572 Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
| 03/31/1998 | US5733569 Drugs for nasal administering |
| 03/31/1998 | US5733567 Emulsification of aqueous solution containing active material with another solution containing copolymer of lactic acid and glycolic acid in chlorinated hydrocarbon, then desolventizing yields microspheres of active material |
| 03/31/1998 | US5733565 Male contraceptive implant |
| 03/31/1998 | US5733559 Cosmetics |
| 03/31/1998 | US5733535 Topical compositions containing N-acetylcysteine and odor masking materials |
| 03/31/1998 | US5733523 Antitumor |
| 03/31/1998 | CA2103462C X-ray contrast agent |
| 03/30/1998 | CA2214441A1 Polymer/hydrogen peroxide complexes |
| 03/26/1998 | WO1998012274A1 Methods and devices for preparing protein concentrates |
| 03/26/1998 | WO1998012243A1 Polymerizable biodegradable polymers including carbonate or dioxanone linkages |
| 03/26/1998 | WO1998012228A1 Polymers containing polysaccharides such as alginates or modified alginates |
| 03/26/1998 | WO1998011920A2 Method of capture of a bioactive agent by a nanoerythrosome preparation |
| 03/26/1998 | WO1998011919A2 Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof |
| 03/26/1998 | WO1998011912A1 Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form |
| 03/26/1998 | WO1998011906A1 Phospholipid drug derivatives |
| 03/26/1998 | WO1998011902A1 Injectable formulations of avermectins and milbemycins |
| 03/26/1998 | WO1998011900A2 Compositions containing cobalamin and amino acids |
| 03/26/1998 | WO1998011887A2 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 03/26/1998 | WO1998011879A1 Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
| 03/26/1998 | WO1998011878A1 Directly compressible lactitol and method |
| 03/26/1998 | WO1998011874A1 Pharmaceutical composition forming a gel |
| 03/26/1998 | WO1998001159A3 Composition for enhanced uptake of polar drugs from mucosal surfaces |